Bavaria’s biotechnology sector continues its growth trajectory. Despite a challenging global market environment, the number of companies in Bavaria’s biopharma sector increased to 548 (+1,5%) in 2025. At the same time, 26 new start-ups were founded (+62,5%) while funding and financing reached a new ...
